| [1] |
LI Xudong, LIU Tong.
The single cell transcriptome sequencing reveals the role and prognostic value of PCLAF and ERO1A in the progression of breast cancer
[J]. Journal of Practical Oncology, 2025, 39(5): 418-427.
|
| [2] |
MA Dongqiong, YANG Cangjiang, ZHU Yunfang, WEN Hongmei, CAO Jidong, DAI Tangyan, LEI Guoyan, LI Dongke, SHI Qingping.
Incidence and mortality of female breast cancer in cancer registration areas of Yunnan Province in 2020 and trend analysis from 2012 to 2020
[J]. Journal of Practical Oncology, 2025, 39(4): 272-277.
|
| [3] |
LUO Danli, LI Fucheng, JIA Siyuan, DOU He, BA Yuling, GAO Tian, LI Zhaoting, XIAO Min.
Effect of plasma atherosclerosis index on pathological complete response and prognosis of breast cancer patients treated with neoadjuvant chemotherapy
[J]. Journal of Practical Oncology, 2025, 39(4): 316-323.
|
| [4] |
WU Dan, WANG Yihai.
Current status of radiotherapy resistance research in breast cancer
[J]. Journal of Practical Oncology, 2025, 39(3): 262-266.
|
| [5] |
WANG Rui, MA Deyuan, JIA Wangqiang, GUAN Quanlin.
Application and progress of nano-medicine mediated cuproptosis in the breast cancer treatment
[J]. Journal of Practical Oncology, 2025, 39(2): 144-150.
|
| [6] |
WANG Shuai, LI Qiqing, LI Rui, XU Tiefeng.
Advances in the application of nanoparticles in the diagnosis and treatment of breast cancer
[J]. Journal of Practical Oncology, 2025, 39(2): 151-156.
|
| [7] |
WANG Ru, ZHANG Hongxia.
Research progress on the application of magnetic resonance imaging technology in predicting lymphatic vascular invasion in breast cancer
[J]. Journal of Practical Oncology, 2025, 39(2): 162-168.
|
| [8] |
GU Wen, ZHOU Lan, JIA Yanni, HUANG Weidong.
Validation of measurement attributes for QLU-C10D scale in breast cancer patients
[J]. Journal of Practical Oncology, 2025, 39(1): 49-55.
|
| [9] |
SHI Changyong, ZHOU Zizhen, ZHOU Guanglin, XIONG Yimin.
The values of DCE-MRI quantitative parameters combined with NCAPH in the diagnosis of early breast cancer
[J]. Journal of Practical Oncology, 2025, 39(1): 56-60.
|
| [10] |
ZHANG Yuqing, JING Jing, LIU Zhaoliang, AN Jing, AN Weiwei.
The alternative splicing event of MZB1 is a potential biomarker of drug resistance in endocrine therapy of breast cancer
[J]. Journal of Practical Oncology, 2024, 38(5): 313-322.
|
| [11] |
YANG Minye, XIAN Tongcheng, LIU Jingjian, BIE Jun, WANG Jie, LUO Yi.
The expression of IL-23 in breast cancer tissues and its correlation with clinicopathological characteristics
[J]. Journal of Practical Oncology, 2024, 38(5): 323-329.
|
| [12] |
LIU Dong, ZHANG Taijuan, DANG Jifeng.
The research progress of inflammatory reaction driving breast cancer metastasis
[J]. Journal of Practical Oncology, 2024, 38(5): 336-341.
|
| [13] |
LI Qianni, XU Lingyan, LI Jian, YAO Xuepei, LIU Meina.
Trend analysis of a longitudinal evaluation for multidimensional treatment quality of breast cancer
[J]. Journal of Practical Oncology, 2024, 38(4): 213-220.
|
| [14] |
GAO Guangqiang, WANG Falin, LI Juan, TIAN Hong, GUO Sijia, YU Xiaolan, YANG Tingting, LIU Jiaren.
β-Ionone suppresses breast cancer cell proliferation through the NF-κB pathway
[J]. Journal of Practical Oncology, 2024, 38(4): 254-261.
|
| [15] |
SHAO Yuming, ZHU Kunbing, ZHANG Jie.
Research progress of SP/NK-1R system in breast cancer
[J]. Journal of Practical Oncology, 2024, 38(4): 268-272.
|